TABLE 1.
Accuracy and precision of D-4F plasma measurements
| Peptide Added (ng/ml) | 1,000 | 200 | 40 | 10 | 1 |
|---|---|---|---|---|---|
| Values obtained from quadruplicates (ng/ml) | 925 | 206 | 41.8 | 9.31 | 1.32 |
| 965 | 192 | 34.5 | 8.46 | 1.17 | |
| 961 | 187 | 35.4 | 7.24 | 0.931 | |
| 1090 | 185 | 35.0 | 6.75 | 1.03 | |
| Mean ± SD | 985.3 ± 72 | 192.5 ± 9.47 | 36.68 ± 3.43 | 7.94 ± 1.16 | 1.11 ± 0.169 |
| 95% CI | (870.5–1100) | (177.4–207.6) | (31.21–42.14) | (6.09–9.79) | (0.84–1.38) |
| CV% | 7.3% | 4.9% | 9.4% | 14.6% | 15.2% |
A plasma sample from an apoE null mouse that had not received peptide was spiked with D-4F to give a plasma concentration of 1,000, 200, 40, 10, or 1 ng/ml. The plasma was extracted and the D-4F concentration was determined in quadruplicate as described in Materials and Methods.